FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease

被引:0
作者
Bernstein, Elana J. [1 ]
Boin, Francesco [2 ]
Elicker, Brett [3 ]
Luo, Yiming [1 ]
Ren, Yawen [4 ]
Zhang, Meng [5 ]
Varga, John [6 ]
Assassi, Shervin [5 ]
机构
[1] Columbia Univ, Irving Med Ctr, Vagelos Coll Phys & Surg, Dept Med,Div Rheumatol, New York, NY USA
[2] Cedars Sinai Med Ctr, Dept Med, Div Rheumatol, Los Angeles, CA USA
[3] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA
[4] Univ Colorado, Dept Med, Div Rheumatol, Denver, CO USA
[5] Univ Texas Hlth Sci Ctr Houston, UTHlth Houston, Dept Med, Div Rheumatol, Houston, TX USA
[6] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
systemic sclerosis; interstitial lung disease; usual interstitial pneumonia; FAM13A; MUC5B; IDIOPATHIC PULMONARY-FIBROSIS; PROMOTER POLYMORPHISM; SUSCEPTIBILITY; GENE; SCLERODERMA; LOCI;
D O I
10.1093/rheumatology/keae573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The MUC58 promoter single nucleotide polymorphism (SNP) rs35705950 has been associated with idiopathic pulmonary fibrosis (IPF) and RA-related interstitial lung disease (ILD), but not with SSc-ILD. We hypothesized that the MUC58 promoter polymorphism or other IPF susceptibility loci are associated with an increased risk for the uncommon SSc-usual interstitial pneumonia (UIP) endophenotype, rather than SSc-ILD in general. Methods: We performed a cross-sectional study of SSc-ILD patients from four US Scleroderma Programs to investigate the frequency of MUC58 rs35705950 and 12 additional IPF susceptibility loci. SSc-ILD patients were stratified by high resolution chest CT (HRCT) imaging findings into UIP and non-UIP groups. Analysis of HRCTs performed by a thoracic radiologist blinded to participants' characteristics classified each scan as definite UIP, probable UIP, indeterminate or alternative diagnosis, according to American Thoracic Society criteria. Results: Four-hundred and eighty-nine SSc-ILD patients were included; 80% were female and 75% were White. Twenty-three (4.7%) patients had a definite UIP pattern. The MUC58 SNP rs35705950 was not associated with a definite UIP pattern in SSc-ILD. In contrast, patients carrying two copies of the IPF risk gene FAM13A minor allele rs2609255 had significantly higher odds of a definite UIP pattern compared with the other patterns (odds ratio 3.40, 95% CI 1.19-9.70), and compared with an alternative diagnosis (odds ratio 3.65, 95% CI 1.25-10.65). Conclusion: We demonstrated a novel association between FAM13A and SSc-UIP. Contrary to IPF and RA-ILD, the MUC58 promoter polymorphism was not associated with a definite UIP pattern in SSc-ILD.
引用
收藏
页数:6
相关论文
共 50 条
[21]   Tomographic Fibrosis Score in the Patients with Systemic Sclerosis-Associated Interstitial Lung Disease [J].
Ozmen, Mustafa ;
Gumus, Cesur ;
Otman, Eda ;
Sinci, Kazim Ayberk ;
Aysin, Idil Kurut ;
Solmaz, Dilek ;
Akar, Servet .
EUROPEAN JOURNAL OF RHEUMATOLOGY, 2023, 10 (03) :107-113
[22]   The role of antifibrotic therapies in the treatment of systemic sclerosis-associated interstitial lung disease [J].
Boleto, Goncalo ;
Avouac, Jerome ;
Allanore, Yannick .
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
[23]   Interstitial Lung Disease Associated with Systemic Sclerosis [J].
Mismetti, Valentine ;
Si-Mohamed, Salim ;
Cottin, Vincent .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) :342-364
[24]   Systemic sclerosis-associated interstitial lung disease: How to manage in 2024? [J].
Bautista-Sanchez, Rocio ;
Khanna, Dinesh .
RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2024, 5 (03) :157-165
[25]   Recent advances in the management of systemic sclerosis-associated interstitial lung disease [J].
Hoffmann-Vold, Anna-Maria ;
Distler, Oliver ;
Crestani, Bruno ;
Antoniou, Katerina M. .
CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (05) :441-447
[26]   Patient and Physician Perspectives on Systemic Sclerosis-Associated Interstitial Lung Disease [J].
Cheema, Tariq J. ;
Young, Meilin ;
Rabold, Erica ;
Barbieri, Ashley N. ;
Baldwin, Nancy ;
Steen, Virginia D. .
CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2020, 14
[27]   Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease [J].
Sydney B. Montesi ;
Peter Caravan .
Current Rheumatology Reports, 2019, 21
[28]   Responses to exercise in systemic sclerosis-associated interstitial lung disease [J].
Donnelly, Ronan P. ;
Smyth, Anita E. ;
Mullan, Charles ;
Riley, Marshall S. ;
Nicholls, D. Paul .
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2023, 43 (04) :253-262
[29]   A new therapy for systemic sclerosis-associated interstitial disease [J].
Kondoh, Yasuhiro .
RESPIRATORY INVESTIGATION, 2020, 58 (04) :227-229
[30]   Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo [J].
Daoussis, Dimitrios ;
Andonopoulos, Andrew P. .
RHEUMATOLOGY INTERNATIONAL, 2011, 31 (06) :841-842